Misguided by INR in Liver Disease Patients? Implications for Clinicians Including Pain Proceduralists

Anesth Analg. 2018 Jul;127(1):289-294. doi: 10.1213/ANE.0000000000002639.

Authors

Jennifer T Mallek¹, Nikolaus Gravenstein, Linda Le-Wendling

Affiliation

¹ From the Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida.

PMID: 29381517
DOI: 10.1213/ANE.0000000000002639

No abstract available

MeSH terms

Anesthesia, Conduction* / adverse effects
Anticoagulants / adverse effects
Blood Coagulation* / drug effects
Clinical Decision-Making
Hemorrhage / chemically induced
Hemorrhage / etiology
Hemorrhage / prevention & control*
Humans
International Normalized Ratio*
Liver Diseases / blood*
Liver Diseases / complications
Liver Diseases / diagnosis
Models, Biological
Pain Management / adverse effects
Pain Management / methods*
Predictive Value of Tests
Reproducibility of Results
Risk Assessment
Risk Factors

Substances

Anticoagulants